375 related articles for article (PubMed ID: 4595320)
21. BCG immunotherapy in patients with malignant melanoma.
Karakousis CP; Douglass HO; Yeracaris PM; Holyoke ED
Arch Surg; 1976 Jun; 111(6):716-8. PubMed ID: 776125
[TBL] [Abstract][Full Text] [Related]
22. Immunotherapy of acute myelogenous leukemia in man.
Powles R
Natl Cancer Inst Monogr; 1973 Dec; 39():243-7. PubMed ID: 4595324
[No Abstract] [Full Text] [Related]
23. Immune response and non-specific immunotherapy in melanoma.
El-Domeiri AA
Ann R Coll Surg Engl; 1978 Mar; 60(2):117-20. PubMed ID: 637492
[TBL] [Abstract][Full Text] [Related]
24. Distant cutaneous granulomas after bacille Calmette-Guérin immunotherapy for malignant melanoma: case for direct infection.
Moff SL; Corey GR; Gottfredsson M
Clin Infect Dis; 1999 Dec; 29(6):1569-70. PubMed ID: 10585816
[No Abstract] [Full Text] [Related]
25. Intralesional BCG in the treatment of metastatic malignant melanoma.
Mastrangelo MJ; Sulit HL; Prehn LM; Bornstein RS; Yarbro JW; Prehn RT
Cancer; 1976 Feb; 37(2):684-92. PubMed ID: 766947
[TBL] [Abstract][Full Text] [Related]
26. Intralesional treatment of recurrent metastatic cutaneous malignant melanoma: a randomized prospective study of intralesional Bacillus Calmette-Guerin versus intralesional dinitrochlorobenzene.
Cohen MH; Jessup JM; Felix EL; Weese JL; Herberman RB
Cancer; 1978 Jun; 41(6):2456-63. PubMed ID: 657108
[TBL] [Abstract][Full Text] [Related]
27. [Results in the use of immunochemotherapy in patients with cutaneous malignant melanoma].
Calbo L; Gorgone S; Palmeri R; Salibra M; Melita P
Chir Ital; 1983 Aug; 35(4):519-25. PubMed ID: 6680859
[TBL] [Abstract][Full Text] [Related]
28. [Immunologic aspects of the treatment of melanoma].
Pawlowska EM
Pol Tyg Lek; 1977 Jun; 32(24):939-41. PubMed ID: 882435
[No Abstract] [Full Text] [Related]
29. Intralesional immunotherapy of melanoma with BCG.
Rosenberg SA; Rapp HJ
Med Clin North Am; 1976 May; 60(3):419-30. PubMed ID: 1271887
[TBL] [Abstract][Full Text] [Related]
30. [Intralesion BCG vaccine therapy in cutaneous melanoma metastasis].
Wolf M; Menzel W
Dermatol Monatsschr; 1978 Sep; 164(9):671-2. PubMed ID: 710658
[No Abstract] [Full Text] [Related]
31. The use of oral BCG in the treatment or metastatic malignant melanoma.
Pritchard KI; Cowan DH; Baker MA; Osoba D; Phillips RA; Clark DA
Med Pediatr Oncol; 1976; 2(2):173-81. PubMed ID: 785199
[TBL] [Abstract][Full Text] [Related]
32. Immunologic defects in melanoma patients: lack of effect of BCG therapy.
Gersten MJ; Hadden EM; Kaplan MH; Pinsky CM; Armstrong D; Hadden JW
Clin Bull; 1977; 7(2):63-9. PubMed ID: 902403
[No Abstract] [Full Text] [Related]
33. Hepatic granulomas and other hepatic lesions associated with BCG immunotherapy for cancer.
Bodurtha A; Kim YH; Laucius JF; Donato RA; Mastrangelo MJ
Am J Clin Pathol; 1974 Jun; 61(6):747-52. PubMed ID: 4598826
[No Abstract] [Full Text] [Related]
34. [Melanoma therapy].
Kleeberg UR
Dtsch Med Wochenschr; 1976 Jun; 101(23):904-8. PubMed ID: 773624
[No Abstract] [Full Text] [Related]
35. Clinical and histologic correlation of melanoma regression after intralesional BCG therapy: a case report.
Mastrangelo MJ; Kim YH; Bornstein RS; Chee DO; Sulit HL; Yarbro JW; Prehn RT
J Natl Cancer Inst; 1974 Jan; 52(1):19-24. PubMed ID: 4590009
[No Abstract] [Full Text] [Related]
36. [Immunoreactivity in patients with surgically removed melanoma in the course of BCG vaccination (author's transl)].
Lochman I; Kyselá T; Machálek J; Lochmanová A; Beska F
Cesk Dermatol; 1980; 55(6):372-7. PubMed ID: 7460040
[No Abstract] [Full Text] [Related]
37. [Clinical administration of BCG-immunotherapy in malignant melanoma (author's transl)].
Wätzig V; Knopf B
Arch Geschwulstforsch; 1979; 49(2):140-5. PubMed ID: 475550
[TBL] [Abstract][Full Text] [Related]
38. Immunotherapy of melanoma with BCG: two fatalities following intralesional injection.
McKhann CF; Hendrickson CG; Spitler LE; Gunnarsson A; Banerjee D; Nelson WR
Cancer; 1975 Feb; 35(2):514-20. PubMed ID: 234291
[TBL] [Abstract][Full Text] [Related]
39. [Immunotherapy with BCG as coadjuvant in the management of malignant melanomas].
Céspedes de Gómez MM; Aguilar Velázquez G; Valles de Cortés Y
Alergia; 1980 Apr; 27(2):69-86. PubMed ID: 7416444
[No Abstract] [Full Text] [Related]
40. [Immunotherapy of melanoma (proceedings)].
Bolund C
Lakartidningen; 1978 Dec; 75(49):4598. PubMed ID: 723350
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
